You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 211 No. 9, March 2, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hormonal Relationships During the Menstrual Cycle

S. S. C. Yen, MD; P. Vela, MD; J. Rankin, MD; A. S. Littell, ScD

JAMA. 1970;211(9):1513-1517.


Abstract

Physiologic fluctuation of follicle-stimulating hormone (FSH), luteinizing hormone (LH), human-growth hormone (HGH), and progesterone concentrations in serum samples of women with ovulatory menstrual cycles were determined by radioimmunoassay and protein-binding assay. During the follicular phase of the cycle, the tonic secretion of FSH showed an initial rise followed by a progressive fall toward the midcycle. In contrast, LH secretion showed a steady increase. A clear elevation of progesterone concentration was observed 48 hours after the onset of a simultaneous surge of LH and FSH at midcycle. Progesterone levels rose rapidly reaching maximal concentration (mean 12.2 mµg/ml) five days after LH surge and remained elevated for five to six days. Thereafter, progesterone levels fell rapidly to an undetectable level on the day after onset of menstruation. This was accompanied by a significant elevation of the FSH and LH levels from their low concentration observed during the late luteal phase. Human-growth hormone levels observed while the patient was in a fasting, ambulant state showed a progressive rise reaching a peak just prior to LH surge and there was a random fluctuation during luteal phase of the cycle.



Author Affiliations

From the departments of reproductive biology and biometry, Case Western Reserve University, School of Medicine, Cleveland. Dr. Vela is a Kellogg Foundation Fellow in Reproductive Biology. Dr. Rankin is now with the Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston.


Footnotes

Reprint requests to MacDonald House, 2105 Adelbert Rd, Cleveland 44106 (Dr. Yen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women
Veldhuis et al.
Am. J. Physiol. Endocrinol. Metab. 2009;297:E483-E489.
ABSTRACT | FULL TEXT  

Estradiol Potentiates Ghrelin-Stimulated Pulsatile Growth Hormone Secretion in Postmenopausal Women
Veldhuis et al.
J. Clin. Endocrinol. Metab. 2006;91:3559-3565.
ABSTRACT | FULL TEXT  

Distinctive Inhibitory Mechanisms of Age and Relative Visceral Adiposity on Growth Hormone Secretion in Pre- and Postmenopausal Women Studied under a Hypogonadal Clamp
Veldhuis et al.
J. Clin. Endocrinol. Metab. 2005;90:6006-6013.
ABSTRACT | FULL TEXT  

No effect of menstrual cycle phase on lactate threshold
Dean et al.
J. Appl. Physiol. 2003;95:2537-2543.
ABSTRACT | FULL TEXT  

Impact of Estradiol Supplementation on Dual Peptidyl Drive of GH Secretion in Postmenopausal Women
Veldhuis et al.
J. Clin. Endocrinol. Metab. 2002;87:859-866.
ABSTRACT | FULL TEXT  

Short-Term Estradiol Replacement in Postmenopausal Women Selectively Mutes Somatostatin's Dose-Dependent Inhibition of Fasting Growth Hormone Secretion
Bray et al.
J. Clin. Endocrinol. Metab. 2001;86:3143-3149.
ABSTRACT | FULL TEXT  

Continuous 24-Hour Intravenous Infusion of Recombinant Human Growth Hormone (GH)-Releasing Hormone-(1-44)-Amide Augments Pulsatile, Entropic, and Daily Rhythmic GH Secretion in Postmenopausal Women Equally in the Estrogen-Withdrawn and Estrogen-Supplemented States
Evans et al.
J. Clin. Endocrinol. Metab. 2001;86:700-712.
ABSTRACT | FULL TEXT  

Oral Estradiol Administration Modulates Continuous Intravenous Growth Hormone (GH)-Releasing Peptide-2-Driven GH Secretion in Postmenopausal Women
Shah et al.
J. Clin. Endocrinol. Metab. 2000;85:2649-2659.
ABSTRACT | FULL TEXT  

Time Mode of Growth Hormone (GH) Entry into the Bloodstream and Steady-State Plasma GH Concentrations, Rather Than Sex, Estradiol, or Menstrual Cycle Stage, Primarily Determine the GH Elimination Rate in Healthy Young Women and Men
Shah et al.
J. Clin. Endocrinol. Metab. 1999;84:2862-2869.
ABSTRACT | FULL TEXT  

Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women
Hornum et al.
J. Appl. Physiol. 1997;82:1946-1951.
ABSTRACT | FULL TEXT  

Acne in Premature Ovarian Failure: Reestablishment of Cyclic Flare-Ups With Medroxyprogesterone Acetate Therapy
Pochi
Arch Dermatol 1974;109:556-557.
ABSTRACT  

No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise
Horton et al.
Am. J. Physiol. Endocrinol. Metab. 2002;282:E752-E762.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.